MOLECULAR ASPECTS OF MEDICINE

Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential

Circulating biomarkers for early detection and clinical management of colorectal cancer.

Developmental pathways in the pathogenesis of lung fibrosis.

Cellular and molecular mechanisms of kidney fibrosis.

Update on genetic predisposition to colorectal cancer and polyposis.

Lifestyle and dietary environmental factors in colorectal cancer susceptibility.

Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity.

Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.

Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.

The beneficial effects of brown adipose tissue transplantation.

Intestinal fibrosis.

The importance of long non-coding RNAs in neuropsychiatric disorders.

Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.

Current concepts of non-coding RNA regulation of immune checkpoints in cancer.

Circulating miRNA analysis for cancer diagnostics and therapy.

MiR-200 family and cancer: From a meta-analysis view.

The extensive role of miR-155 in malignant and non-malignant diseases.

Neurological disorders and mitochondria.

Diabesity-associated oxidative and inflammatory stress signalling in the early human placenta.

Involvement of A2B adenosine receptors as anti-inflammatory in gestational diabesity.

Glucocorticoids and Brown adipose tissue: Do glucocorticoids really inhibit thermogenesis?

Impaired signalling pathways mediated by extracellular vesicles in diabesity.

Diabesity and brain disturbances: A metabolic perspective.

Switching on the furnace: regulation of heat production in brown adipose tissue.

Epithelial keratins: Biology and implications as diagnostic markers for liquid biopsies.

The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities.

Anatomy and physiology of the nutritional system.

The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome.

Mitochondrially-targeted treatment strategies.

Mendelian randomisation: A powerful and inexpensive method for identifying and excluding non-genetic risk factors for colorectal cancer

Diabesity and antidiabetic drugs.

Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.

Blood-based bioenergetics: An emerging translational and clinical tool.

Altered expression of miR-181 affects cell fate and targets drug resistance-related mechanisms.

Switching off the furnace: brown adipose tissue and lactation.

Functional roles of the human ribonuclease A superfamily in RNA metabolism and membrane receptor biology.

Somatic mutational signatures in polyposis and colorectal cancer.

Glioma progression in diabesity.

Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.

Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition.

Altered foetoplacental vascular endothelial signalling to insulin in diabesity.

Emerging isothermal amplification technologies for microRNA biosensing: Applications to liquid biopsies.

Mitochondrial bioenergetics and redox dysfunctions in hypercholesterolemia and atherosclerosis.

Quantification of mitochondrial DNA from peripheral tissues: Limitations in predicting the severity of neurometabolic disorders and proposal of a novel diagnostic test.

Molecular evolution of thermogenic uncoupling protein 1 and implications for medical intervention of human disease.

Cell-free DNA in blood as a noninvasive insight into the sarcoma genome.

Circulating cell-free tumor DNA analysis in pediatric cancers.